Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

Fontanet, Aline; Chalandon, Yves; Roosnek, Eddy Emile; Mohty, Bilal; Passweg, Jakob

doi:10.1038/bmt.2010.285

Scientific article

Letter

English

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

ContributorsFontanet, Aline; Chalandon, Yves; Roosnek, Eddy Emile; Mohty, Bilal; Passweg, Jakob

Published inBone marrow transplantation, vol. 46, no. 9, p. 1272-1273

Publication date2011

Keywords

Adolescent
Adult
Aged
Anti-Infective Agents/adverse effects/therapeutic use
Blood Platelets/physiology
Case-Control Studies
Female
Hematologic Diseases/blood/surgery
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Neutrophils/physiology
Trimethoprim-Sulfamethoxazole Combination/adverse effects/therapeutic use
Young Adult

Affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Research group

Groupe Roosnek Eddy (hémato-oncologie) (19)

Funding

Swiss National Science Foundation - T cell and NK-cell immunity after hematopoietic stem cell transplantation and under inflammatory/anti-inflammatory conditions [310030_127516]

Citation (ISO format)

FONTANET, Aline et al. Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. In: Bone marrow transplantation, 2011, vol. 46, n° 9, p. 1272–1273. doi: 10.1038/bmt.2010.285

Article (Published version)

Identifiers

PID : unige:25202
DOI : 10.1038/bmt.2010.285
PMID : 21102496

ISSN of the journal0268-3369

497views

0downloads

Creation11/02/2012 4:18:00 PM

First validation11/02/2012 4:18:00 PM

Update time03/14/2023 7:54:51 PM

Status update03/14/2023 7:54:51 PM

Last indexation10/18/2023 3:19:48 PM

Archive ouverte UNIGE

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

Technical informations